Skip to main content
Premium Trial:

Request an Annual Quote

Plexxikon Taps Certara's Software for Drug Discovery Data Analysis

Premium

This week, Certara said that Plexxikon has selected its D360 software solution to support data access and analysis for its drug discovery projects.

Certara said that scientists at Plexxikon are using the software to integrate project data and mine structure activity relationships using information from chemical registration and biological assay databases such as Accelrys’ Isentris and Assay Explorer.

The tool also lets users create their own queries and supports collaboration by providing an automated search and analysis workflow that can be shared with other researchers and reused. Furthermore, D360 enables biologists to assess the quality of screening data before they make it available to chemists for additional analysis.

The financial details of the agreement were not disclosed.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.